Medrx Co. Ltd. | Income Statement
Fiscal year is January-December. All values JPY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
68,575.00
26,285.00
37,612.00
22,341.00
198,212.00
8,397
Cost of Goods Sold (COGS) incl. D&A
36,876.00
61,786.00
88,258.00
65,139.00
66,209.00
42,354
Gross Income
31,699.00
35,501.00
50,646.00
42,798.00
132,003.00
33,957
SG&A Expense
636,572.00
967,703.00
949,326.00
1,299,989.00
1,149,716.00
1,239,413
EBIT
604,873.00
1,003,204.00
999,972.00
1,342,787.00
1,017,713.00
1,273,370
Unusual Expense
-
-
116,938.00
28,120.00
43,843.00
1,804
Non Operating Income/Expense
25,794.00
14,072.00
16,321.00
19,475.00
94,182.00
5,679
Interest Expense
7,820.00
-
-
-
-
-
Pretax Income
616,644.00
1,012,115.00
874,026.00
1,254,618.00
880,044.00
1,265,227
Income Tax
5,353.00
4,432.00
4,340.00
4,463.00
4,342.00
2,458
Consolidated Net Income
621,997.00
1,016,547.00
878,366.00
1,259,081.00
884,387.00
1,267,686
Net Income
621,997.00
1,016,547.00
878,366.00
1,259,081.00
884,387.00
1,267,686
Net Income After Extraordinaries
621,997.00
1,016,547.00
878,366.00
1,259,081.00
884,387.00
1,267,686
Net Income Available to Common
621,997.00
1,016,547.00
878,366.00
1,259,081.00
884,387.00
1,267,686
EPS (Basic)
113.48
151.96
131.21
155.48
103.15
126.77
Basic Shares Outstanding
5,481.20
6,689.70
6,694.50
8,097.80
8,573.40
10,000.10
EPS (Diluted)
113.48
151.96
131.21
155.48
103.15
126.77
Diluted Shares Outstanding
5,481.20
6,689.70
6,694.50
8,097.80
8,573.40
10,000.10
EBITDA
576,616.00
950,744.00
923,843.00
1,285,231.00
958,542.00
1,233,459
Non-Operating Interest Income
632.00
1,043.00
921.00
530.00
401.00
659
Equity in Affiliates (Pretax)
30,377.00
24,026.00
8,234.00
15,540.00
758.00
-
About Medrx Co.
View Profile
